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ABSTRACT 
Reliable diagnosis of human helminth infection(s) is essential for ongoing disease 
surveillance and disease elimination. Current WHO-recommended diagnostic assays are 
unreliable in low-endemic near-elimination settings and typically involve the invasive, 
onerous and potentially hazardous sampling of bodily fluids such as stool and blood, as well 
as tissue via biopsy. In contrast, diagnosis by use of non-invasive urine sampling is generally 
painless, more convenient and low risk. It negates the need for specialist staff, can usually be 
obtained immediately upon request and is better accepted by patients. In some instances, 
urine-based diagnostic assays have also been shown to provide a more reliable diagnosis of 
infection when compared to traditional methods that require alternative and more invasive 
bodily samples, particularly in low-endemicity settings. Given these relative benefits, we 
identify and review current research literature to evaluate whether non-invasive urine 
sampling is currently exploited to its full potential in the development of diagnostic tools for 
human helminthiases. Though further development, assessment and validation is needed 
before their routine use in control programmes, low-cost, rapid and reliable assays capable of 
detecting transrenal helminth-derived antigens and cell-free DNA show excellent promise for 
future use at the point-of-care in high-, medium- and even low-endemicity elimination 
settings. 
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INTRODUCTION 
Parasitic worms, often referred to as helminths, form the most common human infectious 
parasites in low- and middle-income countries (LMIC’s), causing a global burden of disease 
exceeding that of both malaria and tuberculosis (Hotez et al., 2008; Lustigman et al., 2012). 
The rapid, straightforward and reliable diagnosis of helminthiases is essential for ongoing 
disease surveillance and successful disease control, particularly as control programmes 
advance towards disease elimination within endemic areas (Figure 1), (Bergquist et al., 2009; 
Gordon et al., 2011; McCarthy et al., 2012; Rollinson et al., 2013; Werkman et al., 2018).  
Current ‘gold standard’ diagnostic assays for the majority of these diseases typically involve 
the invasive and cumbersome sampling of bodily fluids such as stool and blood, as well as 
tissue via biopsy (Table 1), (WHO, 2012). Not only are these procedures often painful, 
onerous and carry a risk of infection (with, for example, HIV), but they also require specific 
equipment and specialist health workers seldom available in endemic areas. A reliable 
assessment of disease prevalence within a given community can therefore often prove 
challenging as a result of patient aversions to being assessed, as well as through a lack of 
resources (Itoh et al., 2011). Although widely considered low-cost, when taking into 
consideration the cumulative costs of equipment, number of personnel needed and 
remuneration of specialist staff, the true costs of gold standard assays are now also being 
realised and may likely be far more expensive than previously assumed (Turner et al., 2017). In 
addition, whilst these techniques may be sufficiently sensitive to confirm or refute individual 
infection status in areas of high disease endemicity or when assessing patients burdened with 
a high-degree of infection, in areas of low-endemicity, for example during control 
programme near-elimination settings, sensitivity of these techniques can seriously wane 
(Appendix 1: Figure 1),  (Bergquist et al., 2009; Klepac et al., 2013; Alhassan et al., 2015; 
Hawkins et al., 2016). 
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In contrast, diagnosis by use of non-invasive urine sampling is generally painless, more 
convenient, less expensive and low risk. It negates the need for specialist staff, can usually be 
obtained immediately upon request and is better accepted by patients (Castillo et al., 2009). 
Further to these clear practical advantages, some urine-based diagnostic assays have also 
been shown to provide a more sensitive diagnosis of infection when compared to traditional 
methods that require alternative and more invasive bodily samples, particularly in low-
endemicity settings  (Sousa-Figueiredo et al., 2013; Adriko et al., 2014). Given these relative 
benefits in ease of collection, greater patient acceptability and possible improved diagnostic 
performance, the following review aims to evaluate whether urine is currently being 
exploited to its full potential with regards to the diagnosis of the major human helminth 
infections and highlight future research needed to further advance helminth urine-diagnostics. 
 
LITERATURE SEARCH STRATEGY  
A systematic online literature search was conducted, beginning in October of 2018 and 
ending in October of 2019. The PubMed, Cochrane Library, Google Scholar and Web of 
Science databases were used, following stipulated database guidelines, to search for any 
literature published between 1919 and 2019 within peer-reviewed journals relevant to 
inputted search terms (National Center for Biotechnology Information., 2019; Cochrane 
Library., 2019; Google Scholar., 2019; Web of Science., 2019). 
Three focal search terms, ‘diagnosis’, ‘diagnostic’ and ‘detection’, were used in conjunction 
with either disease name(s) (e.g., ‘schistosomiasis’, ‘Bilharzia’ and ‘snail fever’ or 
‘lymphatic filariasis’ and ‘elephantiasis’), or pathogen species (e.g., ‘Schistosoma 
haematobium’ or ‘Wuchereria bancrofti’) and ‘urine’ or ‘transrenal’. Following this initial 
search, additional terms were included, such as diagnostic marker (e.g., '‘antigen’) and/or 
assay method (e.g., ‘enzyme-linked immunosorbent assay’), to potentially uncover additional 
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literature. The abstracts of all publication hits were read and assessed for their relevance to 
review. Irrelevant articles were not included in review, whereas all relevant articles were read 
in full. Publications deemed relevant were those that highlighted any primary research 
concerning the detection of any human-infecting parasitic helminth outlined in Table 1, or 
closely related non-human animal-infecting species, within urine samples taken from humans 
or non-human animals. Any secondary research, for example systematic reviews or meta-
analyses, that met these criteria were also included. All literature cited within relevant articles 
was also screened, again to potentially uncover additional literature not provided by initial 
database searches. 
 
MACROSCOPIC CHANGES TO URINE AS A MEANS OF DIAGNOSING 
UROGENITAL SCHISTOSOMIASIS 
Visible haematuria is often indicative of active urogenital schistosomiasis, caused by 
infection with Schistosoma haematobium (Colley et al., 2014). As such, cost-effective 
questionnaires involving either the self-reporting of blood in the urine by patients or the 
observation of blood in the urine by health workers have been used in an attempt to rapidly 
identify infected individuals and disease prevalence within endemic areas (Lengeler et al., 
2002a; b; Okeke and Ubachukwu, 2014; Atalabi et al., 2017). 
The sensitivity of self-reporting the presence of blood in the urine for diagnosis of S. 
haematobium infection has been extensively assessed (Bogoch et al., 2012; Bassiouny et al., 
2014). Comparing patient questionnaire responses to the diagnostic gold standard 
(identification of ova in concentrated urine samples via microscopy), it has been concluded 
that despite the method’s practical advantages and relatively low cost, self-reported 
macrohaematuria alone is unreliable at the individual level primarily because visible 
haematuria typically only presents in individuals burdened with particularly heavy infections 
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(Bogoch et al., 2012). In addition, macrohaematuria is also often a symptom of common 
urinary tract infections and bladder stones (Appendix 1: Figure 1), (Le and Hsieh, 2017). It 
has  also been highlighted that the self-reporting of blood in the urine by school-aged 
children, the demographic customarily selected for helminth surveillance within a given 
community, can be unreliable due to either a young-girl’s reluctance to admit the onset of 
menses, or a young-boy’s eagerness to proclaim his ‘coming of age’ as a result of gross 
haematuria often being considered a natural sign of the onset of puberty (Montresor et al., 
2002; Colley et al., 2014).  
For these reasons, the diagnostic reliability of having trained and experienced personnel 
identify the presence of macroscopic blood in the urine has also been assessed, again, 
comparing the method to urine-egg detection by microscopy (Okeke and Ubachukwu, 2014). 
Once more it was concluded that, unless used in conjunction with more taxing and costly 
methods, macrohematuria does not provide adequate sensitivity when compared to egg 
microscopy, and in using only this method low-, or even moderate-intensity, infections would 
likely be missed.  
It is generally accepted that although a useful and easily implemented tool in initial baseline 
observations to confirm S. haematobium presence in highly-endemic populations, in areas of 
low-endemicity, or when evaluating programmatic intervention success in reducing disease 
prevalence and transmission, alternative and more accurate diagnostic approaches should be 
used (Utzinger et al., 2015; Mutapi et al., 2017). 
 
MICROSCOPIC CHANGES TO URINE AS A MEANS OF DIAGNOSING 
UROGENITAL SCHISTOSOMIASIS 
The current gold standard of S. haematobium diagnosis involves the filtering, staining and 
observation of morphologically distinct eggs excreted in urine (Le and Hsieh, 2017). Using a 
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182019001732
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 03 Jan 2020 at 10:17:03, subject to the Cambridge Core terms of use, available at
  
syringe and polycarbonate filters with a pore size of 8-30 µm, eggs from 10 mL of a well-
shaken urine sample can be isolated, stained and examined under a microscope (Peters et al., 
1976; Colley et al., 2014; Utzinger et al., 2015). This has long been the preferred method of 
S. haematobium diagnosis as it allows for a straightforward and reasonably inexpensive 
means of confirming infection within an individual or presence within a community (through 
sample pooling), using relatively unsophisticated and somewhat field-appropriate equipment. 
Additionally, and importantly, eggs can be quantified; providing a moderately accurate 
assessment of infection intensity within an individual that can then be used to estimate degree 
of clinical morbidity (Colley et al., 2014; Utzinger et al., 2015; Corstjens et al., 2017). 
The many shortcomings of urine-egg microscopy, however, are well understood (Braun-
Munzinger and Southgate, 1992; Le and Hsieh, 2017; Ajibola et al., 2018). Owing to 
heterogeneities in egg output occurring between different periods of the same day, between 
different days and even between different seasons, accurate diagnosis and morbidity 
assessment of any given individual using just one urine sample is unlikely (Braun-Munzinger 
and Southgate, 1992; Le and Hsieh, 2017; Christensen et al., 2018). To mitigate this, multiple 
urine samples from the same individual can be taken over consecutive days, ideally between 
the hours of 10:00am and 2:00pm to coincide with optimum egg passage (Le & Hsieh, 2017). 
Repeated bouts of urine filtration and microscopy is, however, taxing work; a reasonable 
balance between diagnostic accuracy, time spent, and financial cost must be met and even 
then, overt improvements in diagnostic sensitivity are rarely seen (Stothard et al., 2014). 
Differences in diagnostic sensitivity between more and lesser-experienced technicians is also 
often found, further complicating matters when large quantities of urine samples require 
assessment (Knopp et al., 2015). 
Of more urgent concern is urine-egg microscopy’s poor sensitivity when used in areas of 
low- or even moderate-prevalence settings (WHO, 2013; Le and Hsieh, 2017). As egg output 
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declines, the sensitivity of urine-egg microscopy is significantly reduced resulting in a variety 
of challenges beyond just reliably identifying individuals burdened with low-intensity 
infections. Some of these challenges include; accurately estimating clinical morbidity, 
evaluating the impact of programmatic interventions, diagnosing pre-school aged children 
and assessing new diagnostic tools (Stete et al., 2012; Knopp et al., 2013, 2018; Le and 
Hsieh, 2017). Recent concern has also been raised about urine-egg microscopy’s poor 
sensitivity when attempting to detect ‘ultra-light’ infections, regarded as those that result in 
the expulsion of between only one and five eggs per 10 mL of urine (Knopp et al., 2018). 
Given the reproductive biology of schistosomes, just one infected individual excreting such 
minute numbers of eggs that may go on to infect and asexually reproduce within the 
appropriate intermediate freshwater snail host, potentially producing hundreds of cercariae 
per day, can cause the re-infection of an entire community (Colley et al., 2014). As such, in 
elimination settings or where treatment is targeted only to infected individuals that may be 
tracked, reassessed and retreated, any infected individuals must be quickly identified to 
ensure prompt treatment and total interruption of transmission; highlighting the urgent need 
for rapid, simple-to-use diagnostic tools deployable at the point-of-care (POC) and able to 
detect ultra-light infections (Hawkins et al., 2016; Knopp et al., 2018).  
Although macrohematuria may typically only present in those harbouring heavy S. 
haematobium infections, microhaematuria, i.e., trace amounts of blood in the urine not visible 
to the naked-eye, can occur even in moderate- and low-intensity infections and can be 
detected using rapid, simple-to-use and relatively inexpensive reagent-strips that can be used 
at the point-of-care (Ochodo et al., 2015; Le and Hsieh, 2017; Knopp et al., 2018). 
The accuracy of urine-heme reagent-strips, or ‘dipsticks’ for the indirect diagnosis of 
urogenital schistosomiasis have also been extensively assessed (Robinson et al., 2009; Krauth 
et al., 2015; Hassan et al., 2018; Musa and Dadah, 2018; Knopp et al., 2018). Recent reviews 
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and meta-analyses have been undertaken to evaluate their diagnostic accuracy with a specific 
focus on high-, medium- and low-prevalence settings and in populations that have previously 
undergone repeated mass drug administration (MDA) treatment with praziquantel (King and 
Bertsch, 2013; Ochodo et al., 2015). In most cases it has been concluded that although the 
diagnostic performance of urine-heme dipsticks is reduced in low-transmission areas and 
despite a range of possible confounding reasons for the presence of blood in the urine (such 
as urinary tract infections, bladder stones, and menstrual blood), at the population level, 
urine-heme dipsticks should be considered more accurate than urine-egg microscopy 
(Ochodo et al., 2015). In addition, urine-heme dipsticks do not require specially trained 
microscopists, are less influenced by daily fluctuations in egg passage and take far less time 
to carry out (Krauth et al., 2015). It has also been concluded, however, that whilst urine-heme 
dipsticks should continue to be used to monitor the early-stage population-level impact of 
schistosomiasis control programmes (i.e., when assessing the initial baseline prevalence or 
when evaluating changes in overall prevalence after early intervention implementation), in 
elimination settings, or again when treatment is targeted only to infected individuals, neither 
the urine-heme dipstick or urine-egg microscopy can reliably identify individuals burdened 
with low- or ultra-light-intensity infections still capable of maintaining disease transmission 
(Knopp et al, 2018; Ochodo et al., 2015; King & Bertsch, 2013). Further assessment of urine-
heme dipstick diagnostic performance using more sophisticated and sensitive methods such 
as Schistosoma antigen or DNA detection, rather than egg microscopy, has been encouraged 
(King & Bertsch, 2013). 
As well as microhaematuria, leukocyturia (the abnormal presence of white blood cells in the 
urine) and proteinuria (the abnormal presence of proteins in the urine) may also be used as 
proxy to diagnose urogenital schistosomiasis, though both methods been found to be 
significantly less sensitive and specific than urine-heme dipsticks (Ochoco et al., 2015). It 
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has been suggested, however, that the use of urine-heme dipsticks in conjunction with low-
cost and field-deployable assays capable of detecting albuminuria (urine-albumin 
concentrations of >40 mg/L), may provide a reliable diagnosis of infection in high-
endemicity settings whilst also allowing assessment of kidney and urinary tract morbidity 
associated with chronic disease (Rollinson et al., 2005; Sousa-Figueiredo et al., 2009). 
Like macroscopic changes, microscopic changes to urine are now also considered 
insufficiently sensitive to detect S. haematobium infection in low-prevalence settings or 
within individuals harbouring low-level infections. In addition, these changes only occur as a 
result of infection with S. haematobium. In endemic areas, co-infection with multiple 
helminth species is commonplace, highlighting the need for multiplex assays capable of 
reliably detecting multiple helminth species using just one bodily sample.  
 
DETECTION OF ANTI-HELMINTH URINE-ANTIBODIES 
Immunodiagnostic assays for the detection of blood-circulating anti-helminth antibodies have 
been used to diagnose infection with many human-infecting helminthiases (Rebollo and 
Bockarie, 2014; Kemal et al., 2015; Vlaminck et al., 2015; Akue et al., 2018). Of all 
antibody-targeting immunological assays, the most frequently employed is some form of the 
enzyme-linked immunosorbent assay (ELISA), the diagnostic functionality of which relies on 
the highly specific antigen-antibody binding that occurs during the body’s immune response 
to invading foreign pathogens (Lazcka et al., 2007). 
Due to ease of sample procurement relative to blood sampling, the diagnostic potential of 
targeting anti-helminth antibodies expelled within the urine using immunodiagnostic assays 
has also been assessed; targeting and successfully detecting urine-based antibodies 
formulated against a range of helminth species (Table 2). Of those studies comparing the 
diagnostic accuracy between targeting urine- and serum-based antibodies, all reported good 
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182019001732
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 03 Jan 2020 at 10:17:03, subject to the Cambridge Core terms of use, available at
  
association in diagnostic performance whilst no additional effort in urine-sample preparation 
was required, presenting a compelling argument for moving beyond invasive blood-based 
diagnostics (Elhag et al., 2011; Nagaoka et al., 2013; Eamudomkarn et al., 2018).  
Although highly specific even in low-endemicity settings, antibody detection using the 
ELISA requires sophisticated equipment, specially trained health workers and expensive 
reagents that require cold chain typically unavailable to those in disease-endemic regions, 
particularly when hoping to obtain a quantitative diagnosis that indicates degree of infection 
within an individual (Bergquist et al., 2009; Tchuem Tchuenté, 2011). As such, regardless of 
bodily sample taken, these requirements make it difficult to envisage the future scale-up and 
field-deployment of the ELISA at the point-of-care, where simple-to-use, rapid and sensitive 
diagnosis is needed. It is for this reason that much attention has been given to the 
development of simple-to-use point-of-care rapid diagnostic test (POC-RDT) devices capable 
of rapidly detecting blood-circulating anti-helminth antibodies (Weil et al., 2000; Coulibaly 
et al., 2013; Steel et al., 2013). Further development of these for use with urine samples, 
however, is lacking. Two novel transrenal antibody-detecting RDTs that have been developed 
and assessed involve the use of antigen-coated coloured latex beads for the detection of 
filaria-specific IgG4 (Nagaoka et al., 2013), and the filtering of urine to isolate human IgG 
bound to S. haemotobium ova, both requiring significantly less equipment, reagents and 
technical expertise than conventional immunodiagnostic assays (Sheele et al., 2013). 
Although promising, further evaluation for reliability, field-applicability, upscale and 
deployment is needed.  
Another principal concern when targeting antibodies to determine infection status is the 
inability to distinguish between active and past infections owing to high antibody titres 
remaining within the body long after treatment success and infection clearance (Rollinson et 
al., 2013; Utzinger et al., 2015). This becomes particularly problematic when attempting to 
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evaluate the impact of programmatic control strategies in areas that have undergone control 
intervention. As an example, individuals within areas having undergone mass administration 
with albendazole for the treatment of ascariasis may have indeed cleared any infection, 
however any diagnostic assay targeting anti-Ascaris antibodies used to assess these 
individuals may remain positive (Jourdan et al., 2018). In areas where disease elimination is 
sought, it has been suggested that antibody-targeting assays may be appropriate for use with 
young children whom have not yet received treatment as a means of assessing whether 
transmission is still taking place (Jourdan et al., 2018; Takagi et al., 2019). In doing so, 
seroconversion rate, typically somewhere between at least 4 – 8 weeks after initial exposure, 
must be taken into consideration (van Grootveld et al., 2018; Vlaminck et al., 2019). 
Persistent post-infection circulating antibodies also cause difficulty when attempting to 
evaluate the true accuracy of antibody-targeting diagnostic assays; typically performed via 
comparison to gold standard assays that may themselves have poor-sensitivity. In doing this, 
antibody assays will consistently appear highly-sensitive with likely concurrent low positive 
predictive values (PPV), (Appendix 1; Figure 1), whereas individuals testing negative by 
gold standard methods but positive by antibody-detecting methods may plausibly be 
harboring active but low-level infections, or may indeed be currently uninfected after having 
cleared a previous infection (Doenhoff et al., 2004). 
Cross reactivity of antibodies between different helminth genera is also an issue (Genta, 
1988; Lammie et al., 2004; Weerakoon et al., 2015; Lamberton and Jourdan, 2015; Garcia et 
al., 2018; Song et al., 2018). In some cases, genera-, or even species-specific identification of 
infecting helminths is essential for safe treatment strategies, for example when providing 
ivermectin to treat onchocerciasis in loiasis-endemic areas (Gardon et al., 1997), or for 
diagnosis of species-specific pathologies such as female and male genital schistosomiasis 
(Itoh et al., 2011; Vlaminck et al., 2016; Kayuni et al., 2019; Kukula et al., 2019). In 
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circumstances such as these, diagnostic assays with a higher degree of specificity than that of 
antibody-targeting assays are needed. 
Because of the technical, financial and logistical challenges presented by anti-helminth 
antibody detection and when considering the very limited resources available for the 
development and validation of novel diagnostic assays, perhaps focus is best placed 
elsewhere, on more user-friendly, cost-effective and reliable methods. 
 
DETECTION OF HELMINTH-DERIVED URINE-ANTIGENS 
Targeting urine-antigens has multiple advantages over targeting transrenal antibodies; 
detection of antigens indicates active infection; diagnostic assays that target antigens can 
therefore be used to evaluate disease intervention strategies such as MDA and vector control; 
invading parasites may be detected soon after infection and antigen levels generally correlate 
well with parasite load (Corstjens et al., 2014; Worasith et al., 2015; Ochodo et al., 2015; 
Kamel et al., 2019; Sousa et al., 2019). As with antibody detection, good association between 
urine- and serum-based antigen detection has been found in high-, medium- and low-
endemicity settings, further strengthening the argument for moving towards non-invasive 
urine sampling (van Dam et al., 2004; Kamel et al., 2019; Sousa et al., 2019).  
Again, most immunodiagnostic assays used to detect helminth-derived urine-antigens, such 
as conventional ELISAs, are currently unsuited for point-of-care use (Table 3). At present, 
efforts to develop simple-to-use POC-RDTs for the detection of helminth urine-antigens have 
focused primarily on test devices capable of diagnosing urogenital and intestinal 
schistosomiasis, though a point-of-care lateral-flow dipstick to detect O. volvulus-derived 
urine-antigens has been also developed (Ayong et al., 2005). 
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The reliability of urine-antigen POC-RDTs when used in low-endemicity settings or when 
assessing individuals with low-intensity infections that may give unclear ‘trace’ results is, 
however, disputed (Coelho et al., 2016; Peralta and Cavalcanti, 2018). Recent meta-analyses 
suggest that, although more rapid and sensitive than stool-microscopy, under these 
circumstances’ targeting the schistosome urine circulating cathodic antigen (CCA) by use of 
the CCA-POC-RDT is not sufficiently sensitive to reliably detect S. mansoni infection at the 
individual level (Danso-Appiah et al., 2016). It has been concluded that because of their low-
cost, ease of use and patient-compliance, the CCA-POC-RDT may serve as a useful tool for 
disease-prevalence mapping and monitoring of control programmes relevant to S. mansoni in 
high- and medium-endemicity settings. In low-endemicity settings, however, when highly 
sensitive diagnostics capable of detecting low-intensity infections with a range of helminth 
species at the individual level are required, alternative and more sensitive assays are needed.  
Revisions in assay protocols can improve the sensitivity and specificity of RDT’s capable of 
detecting schistosome-urine-antigens beyond that of even lab-based ELISA assays, even in 
light-infections (Coelho et al., 2016; Kamel et al., 2019). Recently, the development of an 
up-converting phosphor lateral-flow (UCP-LF) assay targeting transrenal circulating anodic 
antigens (CAA) has shown that diagnosis of ultra-light schistosome infections through urine-
CAA detection is possible (Corstjens et al., 2014, van Dam et al., 2015a; b). The genus-
specific assay has shown extremely high sensitivity for the detection of S. haemotobium, S. 
mansoni, S. japonicum and S. mekongi urine-CAA, even in low-endemicity settings 
(Corstjens et al., 2014; van Dam et al., 2015a; b; Knopp et al., 2015; de Dood et al., 2018; 
Sousa et al., 2019). Further to its high-specificity, the UCP-LF CAA assay offers additional 
advantages over urine- and stool- microscopy in that the UPC-LF CAA is much higher-
throughput and that only urine sampling is required to diagnose both urogenital and intestinal 
schistosomiasis (Knopp et al., 2015; Corstjens et al., 2014). Though treatment of both forms 
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of schistosomiasis is identical, (40 mg praziquantel per kg body weight), if using this assay in 
areas co-endemic for both S. haemotobium and S. mansoni, additional steps would be 
required to diagnose species-specific infection, associated pathologies, cure rates and drug 
efficacies. 
Although not yet fully suited for point-of-care use, the UCP-LF CAA assay requires only a 
reliable source of electricity, simple centrifugation facilities and pipetting capacities; offering 
a high-throughput and highly-sensitive means of diagnosing schistosomiasis through urine 
sampling whilst requiring lesser-equipped laboratory infrastructure than conventional 
immunodiagnostic assays (Knopp et al., 2015; Sousa et al., 2019). As the assay is also 
currently too expensive for commercial and routine use in schistosomiasis control 
programmes, efforts to develop a less expensive, rapid and simple-to-use CAA-POC-RDT 
that retains the UCP-LF CAA’s high-sensitivity have begun (Knopp et al., 2015). Until then, 
it has been suggested that the existing assay could be used as a robust means of confirming or 
refuting indecisive test results at the individual level given by alternative, less sensitive but 
more field-appropriate, methods (de Dood et al., 2018). 
Additional advancements in antigen-detecting immunodiagnostic POC-RDTs include the 
development of a lateral flow immunochromatographic test strip capable of detecting 
circulating S. mansoni antigen (CSA) within the urine using colloidal gold and mesoporous 
silica nanoparticles (Kamel et al., 2019). Though currently adapted only for diagnosis of 
infection with S. mansoni, these rapid and field-applicable test strips showed extremely high 
sensitivity when used to assess patients burdened with light infections and were even found 
to provide a more sensitive diagnosis than the conventional lab-based sandwich ELISA. 
Further assessment and validation of these RDT test strips, as well as adaptation for detection 
of other helminth-species urine-antigens, is encouraged.  
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It should be noted that the diagnostic potential of targeting any helminth-derived antigen 
through urine sampling will greatly depend on whether or not that antigen is expelled in the 
urine. Blood-circulating antigens with a high molecular mass may be too large to pass from 
the glomerular capillaries into the glomerular capsule and onto the bladder, and even of those 
that do, some will undoubtedly degrade into smaller products not recognised by monoclonal 
antibodies prior to diagnosis (Chanteau et al., 1994). Moreover, some helminth antigens may 
not be expelled in the urine because of that helminth species’ bodily habitat. The adult form 
of Ascaris lumbricoides and various species of cestode, for example, reside within the 
gastrointestinal lumen and so do not directly interact with circulating blood (Lamberton and 
Jourdan, 2015).  
Additionally, as with antibodies, any transrenal antigens targeted for diagnostic purposes will 
require assessment as to whether or not and to the degree with which they may cross-react 
with other antigens and/or other proteins expelled in the urine. Helminth-derived blood-
circulating antigens from various genera of filarial nematode, for example, are known to 
cross-react in co-endemic areas; severely hampering the diagnostic efficacy of assays needed 
to identify infected individuals and provide safe treatment (Hertz et al., 2018). In addition, 
the Schistosoma CCA assay has been found to cross react with antigens from other parasites, 
general inflammatory biomarkers and even metabolites expelled in the urine of pregnant 
women; also hampering diagnostic efficacy (van Dam et al., 1996; Utzinger et al., 2016). 
 
DETECTION OF HELMINTH-DERIVED TRANSRENAL NUCLEIC ACID 
Diagnosis via detection of helminth DNA expelled in the urine has many advantages beyond 
ease of sample procurement; it can be highly sensitive (trace levels of DNA can be detected), 
highly specific, parasite load can be quantified, assays can be high through-put and multiple 
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species of parasitic helminth can be identified within one multiplex assay (Gordon et al., 
2011; Phuphisut et al., 2014; Melchers et al., 2014). Possible further benefits include the 
early detection of anthelminthic drug resistance development, the ability to monitor helminth 
population genetic variation over time, relatively less arduous sample preparation when 
compared to blood, stool or tissue samples and the ability to detect pre-patent infections (Enk 
et al., 2010, 2012; Lamberton and Jourdan, 2015; Minetti et al., 2016).  
Cell Free DNA (cfDNA) has been defined as extracellular fragments of DNA found in bodily 
fluids or tissues, including the urine (Weerakoon et al., 2015; Weerakoon and McManus, 
2016; Weerakoon et al., 2018). It can be detected through use of nucleic acid amplification 
tests (NAATs), the more common of which include conventional polymerase chain reaction 
(PCR), nested PCR (nPCR) and quantitative or real-time PCR (qPCR/rtPCR) (Gordon et al., 
2011; Verweij and Stensvold, 2014). Praised for their high-sensitivity and specificity, 
NAATs are now becoming recognised as a more reliable means of helminth diagnosis than 
current gold standard and immunodiagnostic assays, particularly in low-intensity infections 
and even when targeting cfDNA expelled in the urine (Enk et al., 2012; Ibironke et al., 2012; 
Melchers et al., 2014; Lodh et al., 2016; Krolewiecki et al., 2018). 
To date, using NAATs, numerous studies have evaluated the diagnostic efficacy of targeting 
transrenal cfDNA from helminths known to reside within a range of bodily habitats, all of 
which have reported higher sensitivity when compared to gold standard techniques (Table 4). 
Although the detectible presence of transrenal cfDNA has not yet been confirmed for all 
human-infecting parasitic helminths, as validated assays do currently exist for the detection 
of many helminth species’ cfDNA in other bodily samples, adaptation of these to assess 
presence and diagnostic efficacy of helminth-derived cfDNA within the urine should be 
straightforward (Gordon et al., 2011; Minetti et al., 2016; Weerakoon and McManus, 2016). 
Of particular interest would be to determine the presence of transrenal Onchocerca volvulus 
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and Loa loa cfDNA, given their subcutaneous and deep tissue habitats and understandable 
patient aversions to invasive skin-snip biopsies currently used to confirm onchocerciasis 
infection (Knopp et al., 2012). Of additional interest would be to determine the presence of 
transrenal cfDNA from Trichuris trichiura and hookworm parasites as, despite sharing their 
gastrointestinal tract habitat with Ascaris lumbricoides and cestodes, adult forms do interact 
with circulating blood  (Jourdan et al., 2018). As with A. lumbricoides and cestode urine-
antigen detection, detection of transrenal cfDNA from these helminths may be unlikely. Cell-
free DNA from Strongyloides stercoralis, another gut-dwelling helminth, has been 
successfully detected in urine, though it is speculated this is due to tissue dissemination 
during larval-form autoinfection (Lodh et al., 2016). 
Although clearly a highly sensitive method of confirming or refuting infection, many 
financial, logistical and methodological challenges must be overcome if NAATs are to 
replace current diagnostic standards, regardless of bodily sample taken. Perhaps of primary 
concern are the high costs associated with NAATs, such as PCR and qPCR, when compared 
to current, less costly, gold standard assays. Expensive reagents, sophisticated equipment and 
remuneration of specialist technical staff all contribute to overall expenditure, again resulting 
in a diagnostic assay likely unaffordable to most health workers in resource-poor settings 
(Minetti et al., 2016). Another major challenge is the upscale and field-applicability of assays 
targeting cfDNA. In programmatic elimination settings where rapid and reliable detection of 
few infected individuals is crucial for disease elimination, diagnostic assays must be 
deployable at the point-of-care. Not only are conventional NAATs themselves currently 
unsuited for point-of-care use, but essential sample preparation steps, such as DNA 
extraction, that also require specific laboratory equipment and reagents, prevent the use of 
conventional NAATs anywhere lacking sophisticated laboratory infrastructure. In addition, to 
what extent helminth-derived cfDNA continues to be expelled in the urine after infection 
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clearance is largely unknown and likely varies between parasite species’ bodily habitat and 
degree of previous infection. 
The recently developed loop-mediated isothermal amplification (LAMP) assay shows 
promise for future point-of-care use; DNA fragments are amplified under isothermal 
conditions, negating the need for thermocycling equipment essential for PCR-based assays; 
the assay is rapid; results can be seen with the naked-eye; multiple pathogens can be targeted 
and detected using one assay run; assays can be carried out by non-specialist staff; reagents 
can be lyophilised and initial DNA extraction steps may be less laborious (Gordon et al., 
2011; Zhang et al., 2014; Weerakoon and McManus, 2016; Bayoumi et al., 2016; Deng et 
al., 2019). To date, LAMP has been used to successfully detect and amplify helminth DNA 
from other bodily samples; S. mansoni-derived cfDNA in urine samples taken from 
experimentally infected mouse models; cfDNA of Strongyloides venezuelensis (a rodent-
infecting species) in urine samples taken from experimentally infected rat models and S. 
haematobium DNA in human urine samples (Takagi et al., 2011; Fernández-Soto et al., 
2014, 2016, 2019; Shiraho et al., 2016; Bayoumi et al., 2016; Lagatie et al., 2016). Despite 
these advantages, however, the LAMP assay does still require heat-blocks or waterbaths to 
heat reactions for long periods; often up to two hours. A reliable source of electricity is 
therefore still essential. Furthermore, unlike qPCR/rtPCR, LAMP assays are only semi-
quantitative, meaning estimations of infection intensity are subjective and may vary between 
personnel; individual assays are low-throughput; amplified fragments cannot be sequenced, 
preventing the monitoring of genetic variation in populations over time and ambiguity exists 
around LAMP sensitivity when compared to alternative PCR-based approaches (Verweij and 
Stensvold, 2014; Zhang et al., 2014; Minetti et al., 2016).  
To overcome many of the logistical and methodological challenges presented by PCR-based 
diagnostics, the point-of-care recombinase DNA-polymerase amplification (RPA) assay has 
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182019001732
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 03 Jan 2020 at 10:17:03, subject to the Cambridge Core terms of use, available at
  
also recently been developed and has been used to successfully detect and amplify S. 
japonicum and  F. hepatica cfDNA in human stool samples, as well as S. haematobium DNA 
within human urine samples (Piepenburg et al., 2006; Sun et al., 2016; Xing et al., 2017; 
Cabada et al., 2017; Li et al., 2019; Rostron et al., 2019). Assays to detect S. mansoni DNA 
by use of the RPA have also recently been developed, though these have not yet been tested 
on clinical samples (Poulton and Webster, 2018). 
Capable of detecting even trace levels of DNA, the RPA provides a promising means of 
reliably detecting ultra-light levels of infection in low-endemic areas (Rosser et al., 2015; Lai 
et al., 2017; Poulton and Webster, 2018; Rostron et al., 2019). In addition, the assay itself 
offers many advantages over PCR and qPCR in terms of its methodology and potential use at 
the point-of-care (Aryeetey et al., 2013; Lodh et al., 2014; Sady et al., 2015; Minetti et al., 
2016).  
Firstly, assay reactions take place within a robust, hand-held, easily programmed, portable 
and battery powered device, omitting the need for specialist technical personnel and 
sophisticated laboratory infrastructure. Moreover, assay results can be easily interpreted 
using the same device or, alternatively, via simple-to-use and low-cost lateral-flow 
immunoassay strips; both omitting the need for sophisticated and delicate readout equipment 
(Rosser et al., 2015; Xing et al., 2017; Poulton and Webster, 2018; Rostron et al., 2019). 
Assay reactions are also isothermal; optimal amplification occurs within 25°C - 42°C with 
use of the device’s battery-powered heater, though testing can take place at ambient 
temperature in some endemic areas, or even at body temperature (Crannell et al., 2014; 
Kersting et al., 2014; Minetti et al., 2016). Reaction time at reduced temperatures is, 
however, prolonged. Isothermal reactions not only negate the need for thermocycling 
equipment that may only amplify specific DNA strands based on cycle conditions within one 
cycle run, but also allow for the detection and amplification of DNA from multiple helminth 
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species or even other pathogens, e.g., malaria or intestinal protozoa, using only different 
primer combinations, within the same assay run (Crannell et al., 2016).  Additionally, and 
unlike LAMP amplicons, RPA amplicons can be sequenced, allowing the monitoring of 
genetic variation in populations over time (Oyola et al., 2012). 
Another advantage of RPA over PCR-based techniques is assay runtime; results can often be 
seen within 30 minutes of urine sample procurement as purification of total DNA from urine 
is not required (Kersting et al., 2014; Krõlov et al., 2014; Rosser et al., 2015; Rostron et al., 
2019). Sample preparation is therefor also less laborious and more field-applicable than these 
alternative DNA amplification methods as only crude preparations are needed. In addition, 
assay reagents can be lypholised for easy transportation and can be stored without 
refrigeration even in tropical ambient temperatures for several weeks (Crannell et al., 2014; 
Oriero et al., 2015). 
The RPA assay is, however, much higher in cost when compared to alternative DNA 
amplification approaches. Estimated to cost between 4 USD$ and 5 USD$ per sample, the 
assay is currently too expensive for routine use in population-level control programmes 
within endemic areas (Minetti et al., 2016). With further development, adaptation and uptake 
of the assay, however, the cost per assay sample is very likely to decrease in the near future 
(Rosser et al., 2015). 
Further drawbacks to RPA include, like LAMP, the assay’s low throughput when compared 
to alternative PCR-based methods, though this can be resolved through manufacture of 
larger-capacity devices. In addition, again like LAMP results, RPA results are only semi-
quantitative, making estimations of infection intensity less reliable. As such, the assay in its 
current form may be best suited for small sample sizes and individual test-and-treat scenarios 
in low-endemicity settings.  
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Despite these disadvantages, the RPA is an extremely promising means of rapid, 
straightforward and sensitive diagnosis at the point-of-care in low-endemicity settings. 
Further development and validation of the RPA assay for use in diagnosing helminthiases 
using non-invasive urine sampling, is therefore recommended. 
 
NOVEL BIOMARKERS 
Proteomic and metabolomic technologies can be used to screen bodily samples, including 
urine, to identify novel biomarkers that may potentially be used for diagnostic purposes. 
Using liquid chromatography and mass spectrometry, for example, it was recently reported 
that as many as 31 Schistosoma-derived proteins were differently abundant within the urine 
of patients infected with S. haematobium when compared to an uninfected control group and 
so may be used to detect active infection (Onile et al., 2017). Here, it was also suggested that 
the presence and abundance of some transrenal host-derived proteins such as human 
growth/differentiation factor 15 (GDF15), upregulated in response to organ damage, may 
even provide a reliable means of determining disease severity and infection intensity, and so 
should be further evaluated. 
Eosinophil cationic protein (ECP), involved in the body’s immune response to foreign 
pathogens, has also been found to be significantly elevated in the urine of individuals infected 
with a variety of helminth species including S. haematobium, S. mansoni, O. volvulus, W. 
bancrofti, and hookworm (Klion & Nutman., 2004; Tischendorf et al., 1999; Asuming-
Brempong et al., 2015; Fayez et al., 2010; Tischendorf et al., 2000). In addition to GDF15, 
when assessing the use of transrenal ECP as a biomarker for infection with S. haematobium, a 
positive correlation between expelled ECP and urine egg count was found, suggesting urinal 
ECP may too increase with infection intensity and may therefore potentially be used to assess 
disease severity and worm burden (Leutscher et al., 2008; Leutscher et al., 2000). These 
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findings have since been replicated not only in S. haematobium, but also in S. mansoni 
infections (Asuming-Brempong et al., 2015). More recently, ECP levels in serum samples 
taken from individuals infected with hookworm have also been shown to positively correlate 
with infection intensity (Amoani et al., 2019). Repeated assessment using lesser-invasive 
urine samples was recommended.  
Liquid chromatography has also been used in conjunction with infrared spectrophotometry to 
screen urine for expelled metabolites associated with helminth infections. Using this 
approach, it was reported that two metabolites, 2-methyl-butyramide and 2-methyl-
valeramide, can be detected within the urine of individuals infected with Ascaris (Hall & 
Romanova., 1990). These findings have, however, recently been contested after neither 
metabolite was detected in Indonesian individuals harbouring active Ascaris infections 
(Lagatie et al., 2017). In addition to liquid chromatography, Nuclear magnetic resonance 
(NMR) spectroscopy has been used to screen urine samples taken from mice experimentally 
infected with S. mansoni for expelled metabolites (Wang et al., 2004). A range of transrenal 
metabolites were associated with active infection and so warrant further exploration in human 
urine samples and in other helminth species infections. 
Newly discovered transrenal biomarkers with the potential to indicate active infection, 
parasite burden and morbidity status may help to inform and shape future point-of-care 
diagnostic tools. The continued use of proteomic and metabolomic technologies for 
biomarker discovery is therefore strongly encouraged. 
DISCUSSION 
Rapid, simple-to-use and low-cost diagnostic tools, deployable at the point-of-care and 
reliable in low-endemicity near-elimination settings, are urgently needed to help facilitate the 
elimination of debilitating parasitic helminth diseases. Current WHO-recommended gold 
standard assays do not meet these criteria and typically require invasive and potentially 
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hazardous bodily samples. Many of these criteria are, however, met by non-invasive urine-
based diagnostic assays capable of detecting a range of parasitic helminth species.  
Macroscopic and microscopic changes to urine are not adequately sensitive to detect 
urogenital schistosomiasis in light-infections, preventing their use in near-elimination 
settings. In addition, although anti-helminth antibodies from a range of helminth species can 
be detected within the urine with high sensitivity, technical, financial and logistical 
challenges impede the reliability and routine use of urine-antibody diagnostic assays in 
helminth control programmes. 
POC-RDT devices capable of detecting transrenal helminth-derived antigens may offer a 
simple, rapid, sensitive and low-cost diagnostic format at the point-of-care in high- and 
medium-prevalence settings. Although not currently adequately sensitive in low-endemicity 
settings or at the individual-level in patients burdened with light-infections, technological 
advancements and protocol revisions show promise for future improvements in POC-RDT 
diagnostic sensitivity that may facilitate their use in low-endemicity near-elimination settings.  
Targeting transrenal helminth cfDNA is extremely sensitive and specific even in low-
endemicity settings. The majority of assays capable of detecting urine-cfDNA are, however, 
both unsuited for point-of-care use and unaffordable to most control-programmes in disease-
endemic areas. The recently developed LAMP and RPA assays may offer a promising, 
reliable and field-deployable means of detecting helminth-derived urine-cfDNA and, though 
further research, development and validation is needed before their routine application in 
disease-endemic areas, these assays have the potential for reliable test-and-treat use in low-
endemicity near-elimination settings to rapidly identify lightly-infected individuals capable of 
maintaining disease transmission.  
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The majority of current literature concerned with diagnosing helminthiases through urine 
sampling focuses primarily on the diagnosis of urogenital and intestinal schistosomiasis. As 
outlined here, many other helminth species, from a range of boldly habitats, can be detected 
through non-invasive urine sampling, particularly via targeting transrenal helminth-derived 
antigens and cell-free DNA. As such, the following research priorities are proposed: 
 To ascertain the detectable presence of transrenal antigens and cfDNA from all of the 
major human-infecting parasitic helminth species. 
 To determine any potential cross-reactivity of transrenal helminth-derived antigens 
with other antigens and/or proteins expelled in the urine and decipher how long 
helminth-derived cfDNA continues to be expelled within the urine after infection 
clearance. 
 Further development and validation of rapid diagnostic tests and field-deployable 
assays suitable for point-of-care use and able to reliably detect trace levels of 
helminth-derived urine-antigens and cfDNA known to be expelled in the urine. Assay 
assessment should not use traditional and unreliable gold standard techniques as 
reference, but rather more sensitive and specific assays, such as qPCR, as reference. 
Despite the high financial costs associated with developing, validating and implementing 
novel diagnostic tools, the programmatic and economic benefits, as well as the health benefits 
to those in disease-endemic areas, gained from improved diagnostics capable of detecting 
even trace infections at the point-of-care will very likely outweigh any initial expenditure 
(Turner et al., 2017). The continued investment in and development of reliable, low-cost and 
non-invasive urine-based diagnostic assays deployable at the point-of-care is therefore highly 
encouraged. 
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CONCLUSION 
Sensitive and specific diagnosis of many major parasitic helminthiases at the point-of-care is 
likely possible through non-invasive urine sampling. Though further development, 
assessment and validation is needed before their routine use in control programmes, low-cost 
and rapid assays capable of detecting transrenal helminth-derived antigens and cell-free DNA 
show promise for future use at the point-of-care in high-, medium- and even low-endemicity 
elimination settings. Ultimately, however, until these techniques are more affordable and 
easily implemented, less-reliable assays that require more invasive bodily samples will 
remain the diagnostic standard. 
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Table 1: WHO-recommended diagnostic techniques for major human helminth infections and how technique invasiveness compares to that of urine sampling.   
Disease (also known as) Infectious agent (helminth 
species) 
WHO-recommended diagnostic technique  
(WHO, 2012) 
Degree of sample invasiveness 
relative to urine sampling* 
Urogenital Schistosomiasis 
(Bilharzia/Snail Fever) 
Schistosoma haematobium Identification of ova in concentrated urine sample via microscopy ±  
 
Ascariasis (Roundworm) Ascaris lumbricoides Identification of ova in concentrated faecal smear via microscopy + 
Trichuriasis (Whipworm) Trichuris trichiura + 
Hookworm Infection Ancylostoma duodenale + 
Necator americanus + 
Gastrointestinal Schistosomiasis 
(Bilharzia/Snail Fever) 
Schistosoma mansoni + 
Schistosoma japonicum + 
Schistosoma mekongi + 
Schistosoma guineensis + 
Schistosoma intercalatum + 
Liver Fluke Infection Fasciola hepatica + 
Fasciola gigantica + 
Opisthorchis viverrini + 
Taeniasis (Tapeworm infection) Taenia solium (adult stage) + 
Taenia saginata (adult stage) + 
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Strongyloidiasis (Threadworm 
infection) 
Strongyloides stercoralis Identification of larvae in concentrated faecal smear via microscopy + 
Lymphatic Filariasis 
(Elephantiasis) 
Wuchereria bancrofti Identification of microfilariae in blood smear (taken to coincide with 
blood-circulating periodicity behaviour) via microscopy 
++ 
Brugia malayi ++ 
Brugia timori ++ 
Loiasis (Loa) Loa loa Identification of microfilariae in blood smear via microscopy ++ 
Cysticercosis/neurocysticercosis Taenia solium (larval cysts) MRI or CT brain scan ++ 
Onchocerciasis (River 
Blindness) 
Onchocerca volvulus Identification of microfilariae in multiple skin snips via microscopy +++ 
    
*Positive/negative symbols denote degree of increase in sample invasiveness when compared to urine sampling where: ‘±’ indicates relative comparable invasiveness; ‘+’ 
indicates a moderate increase in sample invasiveness; ‘++’ indicates a considerable increase in sample invasiveness and; ‘+++’ indicates a major increase in sample 
invasiveness. 
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Table 2: Anti-helminth antibodies detected within urine and immunodiagnostic assay used.   
Bodily habitat Species (life stage) Antibody detected Assay used References 
Circulatory system S. mansoni (adult stage) IgG against soluble worm antigen (SWA) ELISA (Elhag et al., 2011) 
S. haematobium (adult stage) IgG against soluble worm antigen (SWA) ELISA (Elhag et al., 2011) 
S. haematobium (ova) IgG against S. haematobium soluble egg antigen (SEA) RDT-sh (Sheele et al., 2013) 
S. japonicum (ova) IgG against S. japonicum soluble egg antigen (SEA) ELISA (Itoh et al., 2003a) 
     
Lymphatic system 
(adult stage/L3  
larval stage) and/or 
circulatory system 
(microfilariae larval  
stage) 
W. bancrofti (life- stage not 
specified) 
Urinary IgG4 against Brugia pahangi crude soluble 
antigen 
Modified ELISA: 
high-density latex 
bead assay 
(Nagaoka et al., 2013) 
ELISA (Itoh et al., 2003b; 
Weerasooriya et al., 
2008) 
Filaria-specific IgG4 ELISA (Rattanaxay et al., 2001; 
Itoh et al., 2007; Samad 
et al., 2013) 
     
Gastrointestinal tract 
(adult stage) and/or 
S.  stercoralis (life- stage not 
specified) 
IgG against S. ratti crude soluble antigen ELISA (Eamudomkarn et al., 
2018) 
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circulatory system 
(larval stage) 
     
Liver O. viverrini (adult stage) IgG, IgA, IgG4 against O. viverrini crude somatic antigen ELISA (Sawangsoda et al., 2012) 
IgG, IgG4 against O. viverrini crude somatic antigen ELISA (Tesana et al., 2007) 
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Table 3: Helminth-derived antigens detected within the urine and immunodiagnostic assay used. 
 
Bodily habitat Species (life stage) Antigen detected Assay used References 
Circulatory system S. mansoni (adult stage) Circulating cathodic antigen (CCA) ELISA (Ochodo et al., 2015; Peralta and 
Cavalcanti, 2018) 
CCA lateral-flow strip POC-RDT (Stothard et al., 2006; Ochodo et 
al., 2015; Peralta and Cavalcanti, 
2018) 
Circulating anodic antigen (CAA) ELISA (Peralta and Cavalcanti, 2018) 
Up converted phosphor-lateral flow 
CAA assay 
(Sousa et al., 2019) 
Circulating Schistosoma mansoni 
antigen (CSA) 
Lateral-flow immunochromatographic 
test strip/ELISA 
(Kamel et al., 2019) 
S. haematobium (adult stage) Circulating cathodic antigen (CCA) ELISA (Stothard et al., 2006; Ochodo et 
al., 2015; Peralta and Cavalcanti, 
2018) 
CCA lateral-flow strip POC-RDT (Peralta and Cavalcanti, 2018) 
Circulating anodic antigen (CAA) ELISA (Peralta and Cavalcanti, 2018) 
Up converted phosphor-lateral flow 
CAA assay 
(Corstjens et al., 2014; Knopp et 
al., 2015; de Dood et al., 2018) 
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 S. japonicum (adult stage) Circulating cathodic antigen (CCA) CCA lateral-flow strip POC-RDT (van Dam et al., 2015) 
Circulating anodic antigen (CAA) Up converted phosphor-lateral flow 
CAA assay 
(van Dam et al., 2015) 
S. mekongi (adult stage) Circulating cathodic antigen (CCA) CCA lateral-flow strip POC-RDT (van Dam et al., 2015; 
Vonghachack et al., 2017) 
Circulating anodic antigen (CAA) Up converted phosphor-lateral flow 
CAA assay 
(van Dam et al., 2015; 
Vonghachack et al., 2017) 
L. loa (microfilariae larval 
stage) 
LOAG_16297 protein Nanobore reversed-phased liquid 
chromatography-tandem mass 
spectrometry (RPLC-MS/MS) 
(Drame et al., 2016) 
O. volvulus (microfilariae 
larval stage) 
Unspecified filarial larval antigen POC-RDT dipstick assay (Ayong et al., 2005) 
     
Lymphatic system 
(adult stage/L3  
larval stage) and/or 
circulatory system 
(microfilariae larval  
stage) 
W. bancrofti (life- stage not 
specified) 
Unspecified filarial antigen Inhibition ELISA (Chenthamarakshan et al., 1996) 
Sandwich ELISA (Huijun et al., 1987) 
Double antibody sandwich ELISA (Ramaprasad et al., 1988) 
Two-site immunoradiometric assay (Henry et al., 1987) 
Counterimmuno-electrophoresis 
(CIEP) 
(Weil et al., 1986) 
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Urinary filarial antigen UFAC2 SDS-PAGE and immunoblotting (Chenthamarakshan et al., 1993) 
B. malayi (life- stage not 
specified) 
Unspecified filarial antigen Sandwich ELISA (Huijun et al., 1987) 
     
Subcutaneous tissue O. volvulus (adult stage) Unspecified filarial antigen Lateral-flow strip POC-RDT (Ayong et al., 2005) 
     
Central nervous 
system 
T. solium (larval stage) Cysticercal antigen B158/B60 Urine Ag-ELISA (Mwape et al., 2011) 
Secretory-excretory antigen Monoclonal antibody Ag-ELISA (Castillo et al., 2009) 
Unspecified T. solium antigen Capture ELISA (Paredes et al., 2016) 
     
Liver O. viverrini (adult stage) Excretory-secretory antigen Modified ELISA (Urine OV-ES) Assay (Worasith et al., 2015) 
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Table 4: Helminth cfDNA detected within the urine and nucleic acid amplification test (NAAT) used. 
 
Bodily habitat Species Antigen detected Assay used References 
Circulatory System S. haematobium 121 bp repeat fragment Dra1 PCR (Shiff et al., 2011; Ibironke et al., 
2012; Lodh et al., 2014) 
RPA (Rostron et al., 2019) 
rDNA internal transcribed spacer (ITS) region PCR (Sandoval et al., 2006) 
77 bp fragment of internal transcribed spacer-2 (ITS2) 
sub-unit 
PCR (Aryeetey et al., 2013) 
Fragments of small subunit SSU rRNA LAMP (Bayoumi et al., 2016) 
Oligonucleotides: F3; B3; FIP; BIP  
(Hamburger et al., 2013) 
LAMP (Lodh et al., 2017) 
77 bp fragment of internal transcribed spacer-2 (ITS2) 
sub-unit 
qPCR/rtPCR (Melchers et al., 2014) 
Variable 267 bp region within cytochrome c oxidase 
subunit 1 (cox1) mitochondrial DNA 
qPCR/rtPCR (Sady et al., 2015) 
S. mansoni  rDNA internal transcribed spacer (ITS) region PCR (Sandoval et al., 2006) 
28S rDNA region PCR (Sandoval et al., 2006) 
110 bp region from highly repeated 121 bp fragment 
(Hamburger et al., 1991) 
PCR (Enk et al., 2012; Lodh et al., 
2013, 2014) 
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Oligonucleotides: F3; B3; FIP; BIP (Hamburger et al., 
2013) 
LAMP (Lodh et al., 2017) 
Unnamed 650 bp mitochondrial S. mansoni 
minisatellite region 
LAMP (Fernández-Soto et al., 2019) 
Fragment of mitochondrial cytochrome c oxidase 
subunit 1 (CO1) gene 
qPCR/rtPCR (Sady et al., 2015) 
S. japonicum  Fragment of mitochondrial cytochrome c oxidase 
subunit 1 (CO1) gene 
PCR (Kato-Hayashi et al., 2015) 
     
Lymphatic system 
(adult stage/L3  
larval stage) and/or circulatory 
system 
(microfilariae larval  
stage) 
W. bancrofti Unnamed tandem-specific region (Kanjanavas et al., 
2005) 
PCR (Ximenes et al., 2014) 
188 bp fragment from SspI repeat sequence PCR (Lucena et al., 1998) 
     
Gastrointestinal tract 
(adult stage) and/or circulatory 
system (larval stage) 
S. stercoralis 124 bp fragment from dispersed repeat sequence 
AY028262 
PCR (Lodh et al., 2016; Krolewiecki et 
al., 2018) 
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Central nervous system T. solium (larval 
stage) 
116 bp fragment from pTsol-9 gene PCR (Toribio et al., 2019) 
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Figure 1: Schematic outlining changes in diagnostic priorities as control programmes 
progress (adapted from Bergquist et al., 2009). 
 
Appendix 1: 
 
Figure 1: Defining sensitivity, specificity and predictive values (Akobeng, 2007; Bergquist 
et al., 2009). 
 
 
High LowMedium
Objective
Reduce 
infection 
intensity and 
associated 
morbidity
Reduce 
prevalence 
and 
transmission
Reduce risk 
of infection
Elimination as 
a public health 
problem
Maintenance of 
elimination 
status
Assess 
infection 
intensity 
and related 
morbidity
Assess 
disease 
prevalence
Assess 
transmission 
and infection 
risk
Determine 
disease 
elimination
Monitoring 
disease 
elimination
Diagnostic 
needs
Simple-to-use
Low cost
Rapid
POC
High-throughput
Multiplex
Quantitative
Sensitive
Simple-to-use
Low cost
Rapid
POC
High-throughput
Multiplex
Quantitative
Sensitive
Simple-to-use
Low cost
Rapid
POC
Multiplex
Capacity to 
detect pathogen 
within host 
vector
Highly sensitive
Simple-to-use
Low cost
Rapid
POC
Capacity to 
detect pathogen 
within host 
vector
Highly sensitive
Highly specific
Rapid
POC
Low cost
Capacity to 
detect pathogen 
within host 
vector
Highly sensitive
Highly specific
Transmission 
Interruption
Disease 
Endemicity
Transmission 
interruption
Diagnostic 
focus
Determine 
transmission 
interruption
Rapid
POC
Low cost
Capacity to
detect pathogen
within host
vector
Highly sensitive
Highly specific
Infected Individuals Uninfected Individuals
D
ia
g
n
o
s
ti
c
O
u
tc
o
m
e
Positive
True Positive
(A)
False Positive
(B)
Positive Predictive Value (PPV):
The probability that a positive result 
accurately indicates the presence of infection
{A/(A+B)}
Negative
False Negative
(C)
True Negative
(D)
Negative Predictive Value (NPV):
The probability that a negative result 
accurately indicates the absence of infection
{D/(C+D)}
Total number infected individuals
(A+C)
Total number uninfected individuals
(B+D)
Sensitivity:
Proportion of infected individuals 
who are correctly identified as such
{A/(A+C)}
Specificity:
Proportion of uninfected individuals 
who are correctly identified as such
{D/(B+D)}
https://www.cambridge.org/core/terms. https://doi.org/10.1017/S0031182019001732
Downloaded from https://www.cambridge.org/core. Liverpool School Of Tropical Medicine, on 03 Jan 2020 at 10:17:03, subject to the Cambridge Core terms of use, available at
